Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:(223)RaCl2
go back to main search page
Accession:CHEBI:74895 term browser browse the term
Definition:A radium molecular entity with formula (223)RaCl2. Used as as a radiotherapeutic agent for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. An alpha-emitter, radium-223 has a half-life of 11.4 days.
Synonyms:exact_synonym: ((223)Ra)radium dichloride
 related_synonym: Formula=Cl2[223Ra];   InChI=1S/2ClH.Ra/h2*1H;/q;;+2/p-2/i;;1-3;   InChIKey=RWRDJVNMSZYMDV-SIUYXFDKSA-L;   Radium-223 dichloride;   SMILES=Cl[223Ra]Cl;   Xofigo
 xref: CAS:444811-40-9;   KEGG:D10398;   PMID:23682134;   PMID:23847352;   PMID:23863050;   Wikipedia:Radium-223_chloride


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19770
    chemical entity 19769
      molecular entity 19767
        isotopically modified compound 1
          (223)RaCl2 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19770
    subatomic particle 19768
      composite particle 19768
        hadron 19768
          baryon 19768
            nucleon 19768
              atomic nucleus 19768
                atom 19768
                  main group element atom 19653
                    p-block element atom 19653
                      halogen 17913
                        chlorine atom 17680
                          chlorine molecular entity 17680
                            elemental chlorine 8381
                              monoatomic chlorine 8362
                                chloride 8362
                                  chloride salt 8362
                                    inorganic chloride 8235
                                      (223)RaCl2 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.